Literature DB >> 18990322

Use of renal function measurements for assessing fracture risk in postmenopausal women.

James T McCarthy1, Andrew D Rule, Sara J Achenbach, Eric J Bergstralh, Sundeep Khosla, L Joseph Melton.   

Abstract

OBJECTIVE: To determine whether factors associated with moderate chronic kidney disease can be used to independently predict fracture risk in postmenopausal white women by analyzing the effect of adding renal function measurements to traditional risk factors (eg, age, body weight, bone mineral density) for fracture risk assessment. PARTICIPANTS AND METHODS: In a prospective, population-based cohort study, postmenopausal women residing in Rochester, MN, with baseline measurements of bone mineral density and renal function were followed up for as long as 25 years for occurrence of fractures. Participants were enrolled in 1980-1984 or 1991-1993, and outcomes were analyzed in 2007. Standardized incidence ratios were used to compare the number of observed fractures with the number of predicted fractures, and potential risk factors were evaluated with Andersen-Gill time-to-fracture regression models.
RESULTS: During 5948 person-years of follow-up of 427 women, 254 women (59.5%) experienced a total of 563 fractures, 394 (70.0%) of which resulted from moderate trauma. Excluding incidentally diagnosed fractures, the 186 clinically diagnosed fractures were statistically undifferentiated from the 195 predicted fractures (standardized incidence ratio, 0.95; 95% confidence interval, 0.82-1.10). No significant trends were observed toward increasing fracture risk with inclusion of quintiles of declining renal function (P>.10). In univariate analyses, serum creatinine concentration, creatinine clearance rate, and estimated glomerular filtration rate were associated with greater risk of some fractures. In multivariate analyses, however, decreasing renal function was not found to be a significant risk factor, after adjusting for age, body weight, and bone mineral density.
CONCLUSION: The addition of serum creatinine concentration, creatinine clearance rate, or estimated glomerular filtration rate does not improve fracture risk prediction in postmenopausal white women who have moderate chronic kidney disease. This result can be partly explained by the fact that important risk factors for decreased renal function (eg, advanced age, lower body weight) are already accounted for in most fracture prediction models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990322      PMCID: PMC2593794          DOI: 10.4065/83.11.1231

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  55 in total

1.  Chronic kidney disease predicts cardiovascular disease.

Authors:  Thomas H Hostetter
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

Review 3.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

4.  Risk factors for hip fracture among patients with end-stage renal disease.

Authors:  C O Stehman-Breen; D J Sherrard; A M Alem; D L Gillen; S R Heckbert; C S Wong; A Ball; N S Weiss
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

5.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

6.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

Authors:  Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick de Zeeuw; Gary C Curhan; Paul E de Jong
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Predictors of new-onset kidney disease in a community-based population.

Authors:  Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

8.  Measured and estimated GFR in healthy potential kidney donors.

Authors:  Andrew D Rule; Hiie M Gussak; Gregory R Pond; Erik J Bergstralh; Mark D Stegall; Fernando G Cosio; Timothy S Larson
Journal:  Am J Kidney Dis       Date:  2004-01       Impact factor: 8.860

9.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

10.  Epidemiologic features of pelvic fractures.

Authors:  L J Melton; J M Sampson; B F Morrey; D M Ilstrup
Journal:  Clin Orthop Relat Res       Date:  1981 Mar-Apr       Impact factor: 4.176

View more
  5 in total

Review 1.  Can one evaluate bone disease in chronic kidney disease without a biopsy?

Authors:  Revekka Babayev; Thomas L Nickolas
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

2.  Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI).

Authors:  K E Ensrud; K Barbour; M T Canales; M E Danielson; R M Boudreau; D C Bauer; A Z Lacroix; A Ishani; R D Jackson; J A Robbins; J A Cauley
Journal:  Osteoporos Int       Date:  2011-05-28       Impact factor: 4.507

3.  Bone mineral density and fracture risk in older individuals with CKD.

Authors:  Robert H Yenchek; Joachim H Ix; Michael G Shlipak; Douglas C Bauer; Nahid J Rianon; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman; Jane A Cauley; Linda F Fried
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

4.  The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis.

Authors:  N A Goto; A C G Weststrate; F M Oosterlaan; M C Verhaar; H C Willems; M H Emmelot-Vonk; M E Hamaker
Journal:  Osteoporos Int       Date:  2019-11-12       Impact factor: 4.507

5.  Analysis of the prevalence, risk factors, and clinical characteristics of osteoporosis in patients with essential hypertension.

Authors:  Hai-Long Wu; Jie Yang; Yu-Chi Wei; Jian-Yu Wang; Yu-Yan Jia; Luan Li; Lu Zhang; Yan Lu; Zong-Jian Luo; Xiang-Yang Leng
Journal:  BMC Endocr Disord       Date:  2022-06-27       Impact factor: 3.263

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.